Arax Advisory Partners’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.13K	Buy	+465	New	+$3.13K	﹤0.01%	2413
2024 Q4	–	Sell	-45	Closed	-$720	–	2748
2024 Q3	$720	Hold	45	–	–	﹤0.01%	2337
2024 Q2	$642	Buy	+45	New	+$642	﹤0.01%	2287